Get Stock Quote Here Rite Aid is a drugstore chain in the United States and a Fortune 500 company headquartered in East Pennsboro Township, Cumberland County, Pennsylvania, near Camp Hill. Rite Aid is the largest drugstore chain on the East Coast and the third largest drugstore chain in the U.S. An offer was presented by Walgreens Boots Alliance in October 2015. Rite Aid accepted the offer and is currently pending government antitrust committee approval. If approved Walgreens would form the world's largest retail pharmacy chain in terms of number of locations. Rite Aid began in 1962 as a single store opened in Scranton, Pennsylvania called Thrift D Discount Center. After several years of growth, Rite Aid adopted its current name and debuted as a public company in 1968. Today, Rite Aid is publicly traded on the New York Stock Exchange under the ticker RAD. Rite Aid reported total sales of US$ 25.5 billion in fiscal year 2014. In 2008, its market capitalization dropped to under $500 million. As of 6 February 2015, the market capitalization of Rite Aid was about $7.15 billion. Its major competitors are CVS andWalgreens. Walgreens announced on October 27, 2015 that it would acquire Rite Aid for $17.4 billion pending approval.
Rite Aid Tops Q4 Earnings Rite Aid Corporation (RAD) Street Actual & Estimate EPS - Last 5 Quarters | FindTheCompany The company witnessed a 20.8% jump in total revenue to $8,270.1 million. However, the top line missed the Zacks Consensus Estimate of $8,468 million. The top-line miss is attributable to soft performance by the Retail Pharmacy segment, offset somewhat by the results of the Pharmacy Services segment. Accounting for the previously announced Walgreens deal, the company did not provide its guidance for fiscal 2017. Deeper Insight Sales at the Retail Pharmacy Segment dipped 0.3% to $6,827 million, primarily due to a fall in comparable store sales (comps). Sales at the newly formed Pharmacy Services segment were $1,530.7 million. The company’s comps fell 0.6%, owing to respective declines of 0.4% and 0.8% in front-end and pharmacy comps, wherein pharmacy comps included a negative impact of 241 basis points (bps) due to the introduction of new generic drugs. However, prescription count at comparable stores improved 0.1%. Prescription sales constituted 68.1% of total drugstore sales and third-party prescription sales accounted for 97.9% of pharmacy sales Rite Aid’s adjusted EBITDA jumped 11.6% year over year to $383 million, whereas adjusted EBITDA margin contracted 40 bps to 4.6%. The rise in adjusted EBITDA, in dollar terms, was mainly due to strong adjusted EBITDA contributions from both Pharmacy Services and Retail Pharmacy. Financials Rite Aid, which trails CVS Health Corporation CVS in size, ended fiscal 2016 with cash and cash equivalents of $124.5 million, long-term debt (excluding current maturities) of $6,914.4 million, and total shareholders’ equity of $581.4 million. In fourth quarter fiscal 2016, the company generated cash flow of $327.9 million from operating activities and incurred gross capital expenditure of nearly $165.2 million. For fiscal 2016, the company generated operating cash flows of $997.4 million, of which $682.6 million was used as gross capital expenditure.
Reported before open today (6/16/16) Earnings: EPS $0.01 Revenue $8.18B Estimates: EPS $0.05 Revenue $8.26B Down 0.58% today so far
RAD right on the 2016 low here... Rite Aid (RAD) Stock Slumps, Kroger Won't Buy Stores NEW YORK -- Shares of Rite Aid (RAD) were sliding in early morning trading on Wednesday as Kroger (KR) may not buy some of the 650 locations Rite Aid and Walgreens Boot Alliance (WBA) need to close to gain approval for their $17 billion proposed merger, sources told the New York Post.
$RAD CEO was laughing at the NY Post said he can't say certain things but was hinting this is a done deal.
Tons of option action on this one, tomorrow is the deadline unless both boards extend it. From what I read it's a sure thing... Somebody is betting big on it, that's for sure. I bought some March 8.00 calls for .42.. Last I checked it was over 60,800 bought today... Imo, this is going to be a big play for some folks...
Down over 17% today on merger agreement price reduction Walgreens (WBA), Rite Aid (RAD) Report Extension to Merger Agreement; Price Revised to $6.50-$7/Share Source: http://www.streetinsider.com/Corpor...+Price+Revised+to+$6.50-$7Share/12472219.html
Jumped in blind on that one, had a lot of folks fooled.. 27 contracts at .42... Oh well, live and learn..
Hard to tell, it dropped through ALL recent support, so the bottom could be anywhere. It's still been selling off on high volume, and did not have a clear bounce yesterday where it saw a lot of buyers coming in to scoop it up at these low prices. Usually when you see the sky falling on these like this, it's best to stay away as there are better options out there. It's kind of like when a stock is up 100%, it's best to look elsewhere as you already missed the jump up. These tend to just be "gamble plays", not investments. The goal of all should be to find a good "investment", whether that be a day trade, swing trade, or long-term investment. Doesn't matter which one. You should be going into a trade with a good idea that it will go up, not just crossed fingers in hopes that maybe you get lucky. If that's anyone's mentality, they're better off at a poker game.
Got some of my money back from this falling knife, had to hit it from a different angle. Went into the trade blind BAD MISTAKE... Done great on SPY and FAS/FAZ today so couldn't focus on my revenge play w RAD... Rule #1 is close the trade when it turns on me. Rule # 2 is close out the contracts daily unless it's a swing trade.. Who knows where bottom is, but play it from both sides..
It's on my hit list AFTER I see some decent movement up or down. I will get my losses back plus some.... LOL..
